Darrell Cass, MD

• Co-President, International Fetal Medicine and Surgery Society
• Chair, Fetal Diagnosis and Therapy Committee, American Pediatric Surgery Association
• Executive Board, North American Fetal Treatment Network
• Surgical Director of Neonatal Intensive Care Unit, Texas Children's Hospital
• Chair, Program Committee, International Fetal Medicine and Surgery Society

• Valedictorian, Agoura High School, Agoura Hills, CA, 1982
• Los Angeles County Medical Association Scholarship, Los Angeles, CA, 1982
• Varsity Letterman Stanford University Baseball Team, 1982-1986
• Borun and Church Scholarships, UCLA School of Medicine, Los Angeles, CA, 1986-1991
• Alpha Omega Alpha, UCLA School of Medicine, Los Angeles, CA, 1990
• Juvenile Diabetes Foundation Postdoctoral Fellowship Award, 1995
• Best paper, American College of Surgeons, South Texas Chapter, 2000, 2001
• Vandenberge-Storz Award for best paper by a young investigator, International Fetal Medicine and Surgery Society, 2001
• Lyndon Baines Johnson Research Award, American Heart Association, Texas Affiliate, 2003
• Molecular Surgeon Research Achievement Award, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 2003
• H Magazine, 2009, 2015
• "Our Best Doctors,” Houstonia Magazine, 2013
• Best Doctor in America, 2006-present
• "Year Best", Houston Medical Journal, 2008
• "Top Doctor,” US News and World Report, 2012
• "Top Doctor," Houstonia Magazine 2017
• "Best of the Best," Houston Chronicle, 2016 (awarded to small number of doctors and two pediatric surgeons in Houston)

• Fellow, American College of Surgeons
• Fellow, Surgical Section, American Academy of Pediatrics
• Member, International Fetal Medicine and Surgery Society
• Member, American Pediatric Surgical Association
• Member, Society of University Surgeons
• Member, Association for Academic Surgery

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-20, Dr. Cass has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.